z-logo
open-access-imgOpen Access
Phenformin Inhibits Hedgehog-Dependent Tumor Growth through a Complex I-Independent Redox/Corepressor Module
Author(s) -
Laura Di Magno,
Simona Manni,
Fiorella Di Pastena,
Sonia Coni,
Alberto Macone,
Sara Cairoli,
Manolo Sambucci,
Paola Infante,
Marta Moretti,
Marialaura Petroni,
Carmine Nicoletti,
Carlo Capalbo,
Enrico De Smaele,
Lucia Di Marcotullio,
Giuseppe Giannini,
Luca Battistini,
Bianca Maria Goffredo,
Egidio Iorio,
Enzo Agostinelli,
Marella Maroder,
Gianluca Canettieri
Publication year - 2020
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2020.01.024
Subject(s) - hedgehog , corepressor , phenformin , hedgehog signaling pathway , chemistry , redox , cancer research , microbiology and biotechnology , medicine , endocrinology , signal transduction , biochemistry , biology , repressor , diabetes mellitus , metformin , gene , organic chemistry , transcription factor
The antidiabetic drug phenformin displays potent anticancer activity in different tumors, but its mechanism of action remains elusive. Using Shh medulloblastoma as model, we show here that at clinically relevant concentrations, phenformin elicits a significant therapeutic effect through a redox-dependent but complex I-independent mechanism. Phenformin inhibits mitochondrial glycerophosphate dehydrogenase (mGPD), a component of the glycerophosphate shuttle, and causes elevations of intracellular NADH content. Inhibition of mGPD mimics phenformin action and promotes an association between corepressor CtBP2 and Gli1, thereby inhibiting Hh transcriptional output and tumor growth. Because ablation of CtBP2 abrogates the therapeutic effect of phenformin in mice, these data illustrate a biguanide-mediated redox/corepressor interplay, which may represent a relevant target for tumor therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom